Two recent studies on the potential of B7-H3-CAR in the treatment of AML have well demonstrated the toxicity of B7-H3-CAR in AML cell lines and primary AML cells, laying a good foundation for the treatment of AML. This evidence concerns the gene CD276 and acute myeloid leukemia.